Complete Remission of Multiple Pulmonary Metastases of Endometrial Adenocarcinoma Treated with a Mixture of Low Molecular Weight Fucoidan and Canvaria gladiata Extract: A Case Report
DOI:
https://doi.org/10.17140/CSMMOJ-8-135Keywords:
Endometrioid adenocarcinoma, Pulmonary metastasis, Docetaxel+Carboplatin (DC) therapy, Hormone therapy, Low molecular weight fucoidan extract (LMF), Canavalia gladiata extract (CG)Abstract
Endometrial cancer (EC) is the most common malignant tumor in post-menopausal women, and the lung is one of the organs to
which endometrial adenocarcinoma metastasizes. Chemotherapy is helpful for various malignancies, but not all are successful. A
71-year-old-Japanese-woman was diagnosed with metastatic lung cancer stage IV of primary endometrial adenocarcinoma. She
received chemotherapy and hormone therapy after a total hysterectomy and pelvic lymphadenectomy. Subsequently, she visited
this clinic for a second opinion as the metastatic lung cancer had repeated remissions and recurrences. Here, the authors report
a case in which complete remission of metastatic lung cancer was achieved by using a product containing low molecular weight
fucoidan extract (LMF) and Canavalia gladiata extract (CG) (LMF-CG) in combination with Medroxyprogesterone acetate (MPA)
hormone therapy.
References
Dendl K, Koerber SA, Finck R, et al. 68Ga-FAPI-PET/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021; 48: 4089-4100. doi: 10.1007/s00259-021- 05378-0
Liu Y, Jin Y, Lu Y, et al. Comparison of the outcomes between laparoscopic surgery and conventional open surgery in treating patients with stage II endometrial carcinoma. Medicine. 2021; 100: 38. doi: 10.1097/MD.0000000000027148
Baiden-Amissah REM, Annibali D, Tuyaerts S, et al. Endo-metrial cancer molecular characterization: the key to identifying high-risk patients and defining guidelines for clinical decision-making? Cancers. 2021; 13: 3988. doi: 10.3390/cancers13163988
Kurra V, Krajewski KM, Jagannathan J, et al. Typical and atypi-cal metastatic sites of recurrent endometrial carcinoma. Canc Imag. 2013; 13(1): 113-122. doi: 10.1102/1470-7330.2013.0011
Mandato VD, Mastrofilippo V, Palicelli A, et al. Solitary vulvar metastasis from early-stage endometrial cancer: Case report and literature review. Medicine. 2021; 100: 22(e25863). doi: 10.1097/ MD.0000000000025863
Liu S, Yang J, Peng X, et al. The natural product fucoidan inhib-its proliferation and induces apoptosis of human ovarian cancer cells: Focus on the PI3K/Akt signaling pathway. Cancer Manag Res. 2020; 12: 6195-6207. doi: 10.2147/CMAR.S254784
Mak W, Wang SK, Liu T, et al. Anti-proliferation potential and content of fucoidan extracted from sporophyll of New Zea-land Undaria pinnatifida. Front Nutr. 2014; 1: Article 9, 1-10. doi: 10.3389/fnut.2014.00009
Aisa Y, Miyakawa Y, Nakazato T, et al. Fucoidan Induces apop-tosis of human HS-Sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol. 2005; 78: 7-14. doi: 10.1002/ajh.20182
Hyun J-H, Kim S-C, Kang J-I, et al. Apoptosis inducing activ-ity of fucoidan in HCT-15 colon carcinoma. Cells Biol Pharm Bull. 2009; 32(10): 1760-1764. doi: 10.1248/bpb.32.1760
Park HS, Kim G-Y, Nam T-J, et al. Antiproliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cancer cells. J Food Sci. 2011; 76, Nr. 3: T77-T83. doi: 10.1111/j.1750-3841.2011.02099.x
Yamasaki Y, Yamasaki M, Tachibana H, et al. Important role of β1-integrin in fucoidan-induced apoptosis via caspase-8 ac-tivation. Biosci Biotechnol Biochem. 2012; 76 (6): 1163-1168. doi: 10.1271/bbb.111001
Atashrazm F, Lowenthal RM, Woods GM, et al. Fucoidan suppresses the growth of human acute promyelocytic leukemia cells in vitro and in vivo. J Cell. Physiol. 2016; 231: 688-697. doi: 10.1002/jcp.25119
Shen J, Li J, Yu P, et al. Research status and hotspots of an-ticancer natural products based on the patent literature and sci-entific articles. Front Pharmacol. 2022; 13: 903239. doi: 10.3389/ fphar.2022.903239
Bobiński M, Okła K, Bednarek W, et al. The effect of fu-coidan, a potential new, natural, anti-neoplastic agent on uterine sarcomas and carcinosarcoma cell lines: ENITEC Collaborative Study. Arch Immunol Ther Exp (Warsz). 2019; 67: 125-131. doi: 10.1007/s00005-019-00534-9
Zhang Z, Teruya K, Yoshida T, et al. Fucoidan extract en-hances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells. Mar. Drugs. 2013; 11(1): 81-98. doi: 10.3390/md11010081
Zhang J, Riby JE, Conde L, et al. A fucus vesiculosus extract inhibits estrogen receptor activation and induces cell death in fe-male cancer cell lines. BMC Complement Altern Med. 2016; 16: 151. doi: 10.1186/s12906-016-1129-6
Hsu H-Y, Lin T-Y, Lu M-K, et al. Fucoidan induces toll-like receptor 4-regulated reactive oxygen species and promotes endo-plasmic reticulum stress-mediated apoptosis in lung cancer. Sci Rep. 2017; 7: 44990. doi: 10.1038/srep44990
Teruya K, Kusumoto Y, Eto H, et al. Selective suppression of cell growth and programmed cell death-ligand 1 expression in HT1080 fibrosarcoma cells by low molecular weight fucoidan extract. Mar Drugs. 2019; 17: 421. doi: 10.3390/md17070421
Mio H. A case of postoperative recurrent breast cancer with multiple lung metastases that completely responded to combi-nation therapy of docetaxel (TXT) and medroxyprogesterone acetate (MPA) [In Japanese]. Jpn J Cancer Chemother. 2003; 30(7): 985-988.
Verma MK., Miki Y, Sasano H. Sex steroid receptors in hu-man lung diseases. J Steroid Biochem Mol Bio. 2011; 127: 216-222. doi: 10.1016/j.jsbmb.2011.07.013
Reis FM, Coutinho LM, Vannuccini S, Batteux F, et al. Proges-terone receptor ligands for the treatment of endometriosis: The mechanisms behind therapeutic success and failure. Hum Reprod Case Report | Volume 8 | Number 1| Tengan I, et al Update. 2020; 26(4): 565-585. doi: 10.1093/humupd/dmaa009
Fedotcheva TA. Clinical use of progestins and their mecha-nisms of action: Present and future (Review). Sovrem Tehnologii Med. 2021; 13(1): 93. doi: 10.17691/stm2021.13.1.11
Mikuła Pietrasik J, Witucka A, Pakuła M, et al. Comprehen-sive review on how platinum and taxane based chemotherapy of ovarian cancer affects biology of normal cells. Cell Mol Life Sci. 2019; 76: 681-697. doi: 10.1007/s00018-018-2954-1
Ho MY, Mackey JR. Presentation and management of docetaxel-related adverse effects in patients with breast cancer. Cancer Manag Res. 2014; 6: 253-259. doi: 10.2147/CMAR.S40601
Gaughran G, Qayyum K, Smyth L, et al. Carboplatin and hy-pomagnesemia: Is it really a problem? Asia-Pac J Clin Oncol. 2020; 1-8. doi: 10.1111/ajco.13481
Numata T, Sato-Numata K, Okada Y. TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to proges-terone in human cervical cancer cells. Physiol Rep. 2019; 7(13): e14157. doi: 10.14814/phy2.14157
Citkowska A, Szekalska M, Winnicka K. Possibilities of fu-coidan utilization in the development of pharmaceutical dosage forms. Mar Drugs. 2019; 17: 458. doi: 10.3390/md17080458
Fitton JH, Stringer DN, Park AY, et al. Therapies from fucoi-dan: New developments. Mar Drugs. 2019; 17: 571. doi: 10.3390/ md17100571
Zhang Z, Teruya K, Eto H, et al. Induction of apoptosis by low-molecular-weight fucoidan through calcium- and caspase-de-pendent mitochondrial pathways in MDA-MB-231 breast cancer cells. Biosci Biotechnol Biochem. 2013; 77(2): 235-242. doi: 10.1271/ bbb.120631
Takahashi H, Kawaguchi M, Kitamura K, et al. An explorato-ry study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients. Integr Cancer Ther. 2018; 17(2): 282-291. doi: 10.1177/1534735417692097
Ye J, Li Y, Teruya K, et al. Enzyme-digested fucoidan extracts derived from seaweed Mozuku of Cladosiphon novae-caledoniae kylin inhibit invasion and angiogenesis of tumor cells. Cytotechnol-ogy. 2005; 47: 117-126. doi: 10.1007/s10616-005-3761-8
Coussens LM, Zitvoge L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: A magic bullet? Science. 2013; 339: 286-291. doi: 10.1126/science.1232227
Bruchard M, Mignot G, Derangère V, et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med. 2013; 19: 57-64. doi: 10.1038/nm.2999
Wagner G, Stollenwerk HK, Klerings I, et al. Efficacy and safety of immune checkpoint inhibitors in patients with ad-vanced non– small cell lung cancer (NSCLC): A system-atic literature review. Oncoimmunology. 2020; 9 (1): 1-16. doi: 10.1080/2162402X.2020.1774314
Brahmer JR, Drake CG, Wollner I, et al. Phase I study of single-agent anti–programmed death-1 (MDX-1106) in refrac-tory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010; 28: 3167-3175. doi: 10.1200/JCO.2009.26.7609
Mahoney KM, Freeman GJ, McDermott DF. The next immune-checkpoint inhibitors: PD-1/PD-L1 blockade in melanoma. Clin Ther. 2015; 37(4): 764-782. doi: 10.1016/j.clinthera.2015.02.018
Su C, Wang H, Liu Y, et al. Adverse effects of anti-PD-1/ PD-L1 therapy in non-small cell lung cancer. Front Oncol. 2020; 10: 554313. doi: 10.3389/fonc.2020.554313
Shirahata S, Katakura Y, Teruya K, et al. Inventors. kit for in-ducing changes in sugar chain structure on the surface of cancer cells. Patent publication number: JP5201499B2. 2013.6.5.
Pinto NV, Cavada BS, Brito LF, et al. Effects of canavalia lectins on acute inflammation in sensitized and non-sensitized rats. Inflammation. 2013; 36(3): 713-722. doi: 10.1007/s10753-013- 9596-0
Yau T, Dan X, Ng CCW, et al. Lectins with potential for anti-cancer therapy. Molecules. 2015; 20: 3791-3810. doi: 10.3390/mol-ecules20033791 Submit your article to this journal | https://openventio.org/submit-manuscript/
Une S, Nonaka K, Akiyama J. Lectin isolated from Japanese red sword beans (Canavalia gladiata) as a potential cancer chemo-preventive agent. J Food Sci. 2018; 83: Nr. 3. doi: 10.1111/1750- 3841.14057
Li W-w, Yu J-y, Xu H-l et al. Concanavalin A: A potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angio-genesis for cancer therapeutics. Biochem Biophys Res Commun. 2011; 414: 282-286. doi: 10.1016/j.bbrc. 2011.09.072
Chung H-J, Park C-J, Lim J-H, et al. Establishment of a refer-ence interval for natural killer cell activity through flow cytom-etry and its clinical application in the diagnosis of hemophago-cytic lymphohistiocytosis. Int Jnl Lab Hem. 2010; 32: 239-247. doi: 10.1111/j.1751-553X. 2009.01177.x
Hou H, Mao L, Wang J, et al. Establishing the reference inter-vals of NK cell functions in healthy adults. Hum Immunol. 2016; 77: 637-642. doi: 10.1016/j.humimm.2016.05.022
Zhang Z, Teruya K, Eto H, et al., Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism involving the ROS-dependent JNK activation and mitochondria-mediated pathways. PLoS One. 2011; 6(11): e27441. pii: e27441.
Zhang Z, Teruya K, Yoshida T, et al., Fucoidan extract en-hances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells. Marine drugs. 2013 Jan 09;11(1): 81-98. doi: 10.3390/md11010081
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
